These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30349208)

  • 61. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes.
    Angulo JC; Brenes FJ; Lizarraga I; Rejas J; Trillo S; Ochayta D; Arumi D
    Actas Urol Esp; 2016 Apr; 40(3):173-82. PubMed ID: 26811022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.
    Arlandis S; Ruiz MA; Errando C; Villacampa F; Arumí D; Lizarraga I; Rejas J
    Clin Drug Investig; 2012 Aug; 32(8):523-32. PubMed ID: 22741748
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs.
    Atkinson-Clark E; Charokopou M; Van Osselaer N; Hiligsmann M
    Epilepsy Behav; 2018 Feb; 79():58-67. PubMed ID: 29248866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in Japan.
    Sugitani Y; Ito K; Ono S
    Front Pharmacol; 2021; 12():697711. PubMed ID: 34354590
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patients' priorities in selecting chronic lymphocytic leukemia treatments.
    Mansfield C; Masaquel A; Sutphin J; Weiss E; Gutierrez M; Wilson J; Boeri M; Li J; Reyes C
    Blood Adv; 2017 Nov; 1(24):2176-2185. PubMed ID: 29296865
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
    Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
    Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A non-interventional cross-sectional re-contact study investigating the relationship between overactive bladder and frailty in older adults in Japan.
    Yoshida M; Satake S; Ishida K; Tanaka Y; Ukai M
    BMC Geriatr; 2022 Jan; 22(1):68. PubMed ID: 35062875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
    Kakizaki H; Lee KS; Yamamoto O; Jong JJ; Katou D; Sumarsono B; Uno S; Yamaguchi O
    Eur Urol Focus; 2020 Jul; 6(4):729-737. PubMed ID: 31718957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 72. Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
    Carrascosa Carrillo JM; Baselga Torres E; Gilaberte Calzada Y; Jurgens Martínez YN; Roustan Gullón G; Yanguas Bayona JI; Gómez Castro S; Ferrario MG; Rebollo Laserna FJ
    Dermatol Ther (Heidelb); 2022 May; 12(5):1197-1210. PubMed ID: 35445962
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment preferences among patients with mild-to-moderate atopic dermatitis.
    Myers K; Silverberg JI; Parasuraman S; Pierce A; Eichenfield LF; Poulos C
    J Dermatolog Treat; 2023 Dec; 34(1):2215356. PubMed ID: 37259544
    [No Abstract]   [Full Text] [Related]  

  • 74. Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder.
    Gotoh M; Kobayashi T; Sogabe K
    Neurourol Urodyn; 2015 Nov; 34(8):730-5. PubMed ID: 25212503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of OAB symptoms on work, quality of life and treatment-seeking behavior in Brazil.
    Gomes CM; Averbeck MA; Koyama M; Soler R
    Curr Med Res Opin; 2020 Aug; 36(8):1403-1415. PubMed ID: 32329367
    [No Abstract]   [Full Text] [Related]  

  • 76. [The new era in the pharmacological treatment of overactive bladder (OAB): mirabegron--a new selective beta3agonist].
    Rechberger T; Kulik-Rechberger B; Miotła P; Wróbel A
    Ginekol Pol; 2014 Mar; 85(3):214-9. PubMed ID: 24783434
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer.
    Hollin IL; González JM; Buelt L; Ciarametaro M; Dubois RW
    MDM Policy Pract; 2020; 5(1):2381468320928012. PubMed ID: 32596504
    [No Abstract]   [Full Text] [Related]  

  • 79. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
    Villacampa F; Ruiz MA; Errando C; Arlandis S; Arumí D; Lizarraga I; Rejas J
    Int Urogynecol J; 2013 Apr; 24(4):573-81. PubMed ID: 23111865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
    Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
    Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.